Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review

por Kobayashi, Masaki, Sawada, Kenjiro, Kimura, Tadashi
Publicado 2017

Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer

por Shimizu, Aasa, Sawada, Kenjiro, Kimura, Tadashi
Publicado 2020

The Role of MicroRNAs in Ovarian Cancer

por Kinose, Yasuto, Sawada, Kenjiro, Nakamura, Koji, Kimura, Tadashi
Publicado 2014

Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer

por Sawada, Kenjiro, Ohyagi-Hara, Chifumi, Kimura, Tadashi, Morishige, Ken-ichirou
Publicado 2012

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

por Nakamura, Koji, Sawada, Kenjiro, Yoshimura, Akihiko, Kinose, Yasuto, Nakatsuka, Erika, Kimura, Tadashi
Publicado 2016

Pure Primary Ovarian Squamous Cell Carcinoma Perforating the Rectum

por Mimura, Kazuya, Okada, Aiko, Haraguchi, Naotsugu, Sawada, Kenjiro, Tomimatsu, Takuji, Kimura, Tadashi
Publicado 2017

Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing

por Sumitani, Naoki, Ishida, Kyoso, Sawada, Kenjiro, Kimura, Tadashi, Kaneda, Yasufumi, Nimura, Keisuke
Publicado 2022

Efficacies of uterine artery embolization for symptomatic uterine fibroids using gelatin sponge: a single-center experience and literature review

por Toda, Aska, Sawada, Kenjiro, Osuga, Keigo, Maeda, Noboru, Higashihara, Hiroki, Sasano, Tomoyuki, Tomiyama, Noriyuki, Kimura, Tadashi
Publicado 2016

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target

por Nakamura, Koji, Sawada, Kenjiro, Kobayashi, Masaki, Miyamoto, Mayuko, Shimizu, Aasa, Yamamoto, Misa, Kinose, Yasuto, Kimura, Tadashi
Publicado 2019

A case of laparoscopic surgery for endometrial cancer in a patient previously treated with a transvaginal mesh procedure for pelvic organ prolapse

por Yoshino, Kiyoshi, Kobayashi, Eiji, Endo, Masayuki, Kakuda, Mamoru, Okada, Aiko, Tomimatsu, Takuji, Sawada, Kenjiro, Takemura, Masahiko, Kimura, Tadashi
Publicado 2017

Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)

por Oride, Tadashi, Sawada, Kenjiro, Shimizu, Aasa, Kinose, Yasuto, Takiuchi, Tsuyoshi, Kodama, Michiko, Hashimoto, Kae, Kobayashi, Eiji, Nakatani, Eiji, Kimura, Tadashi
Publicado 2023

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

por Takahashi, Ryoko, Mabuchi, Seiji, Kawano, Mahiru, Sasano, Tomoyuki, Matsumoto, Yuri, Kuroda, Hiromasa, Kozasa, Katsumi, Hashimoto, Kae, Sawada, Kenjiro, Kimura, Tadashi
Publicado 2016

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene

por Toda, Aska, Sawada, Kenjiro, Yoshimura, Akihiko, Nakatsuka, Erika, Kuroda, Hiromasa, Kozasa, Katsumi, Miyamoto, Mayuko, Hashimoto, Kae, Mabuchi, Seiji, Kimura, Tadashi
Publicado 2017

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy

por Yoshimura, Akihiko, Sawada, Kenjiro, Sasano, Tomoyuki, Kuroda, Hiromasa, Kozasa, Katsumi, Nakatsuka, Erika, Nakamura, Koji, Hashimoto, Kae, Mabuchi, Seiji, Kimura, Tadashi
Publicado 2018

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study

por Kobayashi, Masaki, Sawada, Kenjiro, Yoshimura, Akihiko, Yamamoto, Misa, Shimizu, Aasa, Shimura, Kotaro, Komura, Naoko, Miyamoto, Mayuko, Ishida, Kyoso, Kimura, Tadashi
Publicado 2020

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

por Miyamoto, Mayuko, Sawada, Kenjiro, Nakamura, Koji, Yoshimura, Akihiko, Ishida, Kyoso, Kobayashi, Masaki, Shimizu, Aasa, Yamamoto, Misa, Kodama, Michiko, Hashimoto, Kae, Kimura, Tadashi
Publicado 2020

The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma

por Kinose, Yasuto, Sawada, Kenjiro, Nakamura, Koji, Sawada, Ikuko, Toda, Aska, Nakatsuka, Erika, Hashimoto, Kae, Mabuchi, Seiji, Takahashi, Kazuhiro, Kurachi, Hirohisa, Lengyel, Ernst, Kimura, Tadashi
Publicado 2015

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

por Kobayashi, Masaki, Sawada, Kenjiro, Nakamura, Koji, Yoshimura, Akihiko, Miyamoto, Mayuko, Shimizu, Aasa, Ishida, Kyoso, Nakatsuka, Erika, Kodama, Michiko, Hashimoto, Kae, Mabuchi, Seiji, Kimura, Tadashi
Publicado 2018

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

por Nakamura, Koji, Sawada, Kenjiro, Miyamoto, Mayuko, Kinose, Yasuto, Yoshimura, Akihiko, Ishida, Kyoso, Kobayashi, Masaki, Shimizu, Aasa, Nakatsuka, Erika, Hashimoto, Kae, Mabuchi, Seiji, Kimura, Tadashi
Publicado 2019

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

por Kawano, Mahiru, Mabuchi, Seiji, Matsumoto, Yuri, Sasano, Tomoyuki, Takahashi, Ryoko, Kuroda, Hiromasa, Kozasa, Katsumi, Hashimoto, Kae, Isobe, Aki, Sawada, Kenjiro, Hamasaki, Toshimitsu, Morii, Eiichi, Kimura, Tadashi
Publicado 2015